Literature DB >> 28875365

The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer.

Ali Ayhan1, Emre Günakan2, İrem Alyazıcı1, Nihan Haberal3, Özden Altundağ4, Polat Dursun1.   

Abstract

PURPOSE: A low albumin level has been reported to be a prognostic factor for various cancers. The aim of this study was to determine the association between preoperative serum albumin level and survival in patients with epithelial ovarian cancer (EOC).
METHODS: Records of 337 patients with EOC that underwent optimal cytoreductive surgery were retrospectively reviewed. Threshold albumin level was planned as 32.5 g L-1 due to the statistical analyses.
RESULTS: Mean overall survival was 51.5 months. Area under the ROC curve was found statistically significant for the discriminative role of albumin for survival outcome (AUC = 0.857, 95% CI 0.813-0.90, P < 0.001). The best cut-off point for albumin was determined as 32.5 g L-1. The sensitivity rate, specificity rate, positive and negative predictive values, and accuracy rate for this cut-off level were found 67.2, 91.2, 81.2, 83.1, and 82.5%, respectively. Preoperative hypoalbuminemia was noted in 101 (30.0%) of the patients, of which 6.2% had an albumin level <25 g L-1. The albumin level was independently and significantly associated with overall survival (HR 2.6; 95% CI 2.1-3.1; P < 0.001). Subgroup analysis showed that patients with an albumin level <32.5 and ≥32.5 g L-1 had mean estimated overall survival of 40.6 and 96.0 months, respectively. Age, stage, and presence of ascites were the other independent significant factors.
CONCLUSIONS: The preoperative albumin level is an independent prognostic factor for overall survival in optimally debulked EOC patients. Further investigations about preoperative albumin level in prognostic models will contribute to the literature.

Entities:  

Keywords:  Optimal debulking; Ovarian cancer; Overall survival; Preoperative albumin

Mesh:

Substances:

Year:  2017        PMID: 28875365     DOI: 10.1007/s00404-017-4511-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  14 in total

1.  Predicting Overall Survival Using Preoperative Nutritional and Inflammation Status for Colorectal Cancer.

Authors:  Tamuro Hayama; Tsuyoshi Ozawa; Mitsuo Tsukamoto; Yoshihisa Fukushima; Ryu Shimada; Keijiro Nozawa; Keiji Matsuda; Shoichi Fujii; Takeo Fukagawa; Yojiro Hashiguchi
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Authors:  Min Li; Tianjiao Zhang; Jing Zhu; Yuebo Li; Wenying Chen; Yanhu Xie; Wei Zhang; Rongzhu Chen; Wei Wei; Guihong Wang; Jiwei Qin; Weidong Zhao; Dabao Wu; Zhen Shen; Björn Nashan; Ying Zhou
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

3.  Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis.

Authors:  Malika Kengsakul; Gatske M Nieuwenhuyzen-de Boer; Suwasin Udomkarnjananun; Stephen J Kerr; Christa D Niehot; Heleen J van Beekhuizen
Journal:  J Gynecol Oncol       Date:  2022-06-07       Impact factor: 4.756

4.  Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.

Authors:  Feng Qi; Yunqiu Xu; Yuxiao Zheng; Xiao Li; Yang Gao
Journal:  Ann Transl Med       Date:  2019-10

5.  Prognostic significance of preoperative serum albumin in epithelial ovarian cancer patients: a systematic review and dose-response meta-analysis of observational studies.

Authors:  Li-Na Ge; Feng Wang
Journal:  Cancer Manag Res       Date:  2018-04-17       Impact factor: 3.989

6.  Prognostic value of preoperative hyponatremia in patients with epithelial ovarian cancer.

Authors:  Jing-Yi Guo; Ting-Ting Gong; Zhuo Yang; Yi Liu; Ling Wang; Ya-Nan Wang; Qi-Jun Wu
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

7.  Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer.

Authors:  Yuan Li; Jia-Ni Yang; Shan-Shan Cheng; Yu Wang
Journal:  Cancer Manag Res       Date:  2019-08-14       Impact factor: 3.989

8.  Controlling Nutritional Status Score Evaluates Prognosis in Patients With Non-Muscle Invasive Bladder Cancer.

Authors:  Jiaguo Huang; Liwei Zhao; Kai Wang; Ji Sun; Shengcheng Tai; Runmiao Hua; Yufu Yu; Yi Fan
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

9.  Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.

Authors:  Weiwei Zhang; Kejun Liu; Bin Ye; Weijiang Liang; Yazhou Ren
Journal:  Cancer Med       Date:  2017-11-28       Impact factor: 4.452

10.  Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.

Authors:  Xiaodi Yang; Hongjian Liu; Minfu He; Meitian Liu; Ge Zhou; Ping Gong; Juan Ma; Qi Wang; Wenjing Xiong; Zheng Ren; Xuanxuan Li; Xiumin Zhang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.